PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for March 14, 2008 Subscribe to this News Feed    
 

Dr. Erika Schwartz Congratulates Wall Street Journal for Recognizing the Existence of Bioidentical Hormones

"The FDA is so ignorant of the facts, it is now cracking down on the compounding pharmacies that make some bioidenticals and is also trying to ban a key bioidentical estrogen, estriol which is not only safe but has been used extensively in Europe for decades. It has also been shown to help women with multiple sclerosis."

Nework, NY (PRWEB) March 14, 2008 -- The Wall Street Journal should be congratulated for coming to grips with the fact that not all HRT products are the same, says Erika Schwartz MD in her latest blog at www.drerika.com.

Until now synthetics, horse urine derivatives, bioidenticals and over-the-counter "naturals" have been lumped together as "dangerous" by a media too lazy to do its homework and which slavishly turns to the same old special interests for its information, Dr Erika writes.

"The confusion was encouraged by pharmaceutical companies and the FDA which erroneously stated that all HRT products pose the same risks regardless of differences in chemical formula and that bioidenticals are a 'marketing term' not to be used by public or medical practitioners," she says.

"The FDA is so ignorant of the facts, it is now cracking down on the compounding pharmacies that make some bioidenticals and is also trying to ban a key bioidentical estrogen, estriol which is not only safe but has been used extensively in Europe for decades. It has also been shown to help women with multiple sclerosis."

Dr Erika says the Journal article (March 11, 2008) is the first time she's seen the mainstream media acknowledge bioidenticals as more than just "marketing terms" and give them the recognition they deserve.

She cautions that the case for bioidenticals is being undermined by the activities of former TV actress and infomercial star Suzanne Somers and her sidekick T.S. Wiley.

"Their lack of credibility has kept bioidenticals on the fringe and raised more doubts about compounding than necessary. Conventional and scientifically-minded doctors are not sold on having Suzanne Somers or T.S. Wiley as leaders in the educational processes associated with treatment of women with hormone issues," she writes

"Unfortunately their showboating has given fuel to many in the mainstream that only fringe doctors work with bioidenticals, This could not be further from the truth. Bioidentical hormones, as noted in the Journal article are commercially available, meaning FDA approved, and the same active hormones found in the commercial formulations are those used by compounding pharmacies in the personalized products prescribed by many leaders in the field of women's health."

www.drerika.com is dedicated to providing an independent, honest view on healthcare topics and issues from a position of devoted patient advocacy.

Its founder, Erika Schwartz, MD is an internationally-recognized patient advocate, practicing physician, expert in conventional and integrative medicine, author of four books and a frequent guest on TV and radio. DrErika.com doesn't tailor its stories to suit sponsors -- it does not accept sponsors.

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RW1wdC1aZXRhLUhvcnItU3VtbS1Ib3JyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Ken Chandler
2128733420
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move